Robert Gagnon
Directeur/Membre du Conseil chez PURPLE BIOTECH LTD
Fortune : 192 759 $ au 30/04/2024
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Eric Rowinsky | M | 67 | 14 ans | |
James Green | M | 65 | 9 ans | |
Dan Paterson | M | 63 | 13 ans | |
Gil Efron | M | 57 | 6 ans | |
Daniel Calkins | M | 37 | 6 ans | |
Peter Smith | M | - |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | - |
Caroline Dorsa | F | 64 | 14 ans | |
Brian Stuglik | M | 64 | 7 ans | |
Jeffrey Frelick | M | 59 | 9 ans | |
Michael Kauffman | M | 60 | 12 ans | |
Simcha Rock | M | 73 | 11 ans | |
Ido Agmon | M | 46 | 8 ans | |
Suzana Nahum Zilberberg | F | 53 | 3 ans | |
Katherine Eade | F | 50 | 7 ans | |
Thomas Loewald | M | 61 | 7 ans | |
Michelle Robertson | F | 57 | 3 ans | |
Jeffrey A. Duchemin | M | 58 |
KD Scientific, Inc.
KD Scientific, Inc. Medical SpecialtiesHealth Technology KD Scientific, Inc. provides liquid handling products. It offers syringe pumps, evaporators, concentrators, and accessories. The company was founded on May 02, 1991 and is headquartered in Holliston, MA. | - |
Isaac Israel | M | 44 | 12 ans | |
Bruce Stroever | M | 75 | 12 ans | |
Stephen Sherwin | M | 75 | 14 ans | |
Anil Kapur | M | 54 | 2 ans | |
Ori Hershkovitz | M | 49 | 3 ans | |
Paul Bunn | M | 79 | 3 ans | |
Yael Margolin | M | 70 | 1 ans | |
Lior Fhima | M | - | 2 ans | |
Michael Schickler | M | 55 | 4 ans | |
Cathy Carew | F | - | - | |
Bertrand Loy | M | 58 | 10 ans | |
John Johnson | M | 66 | 4 ans | |
Siddhesh Angle | M | 39 | - | |
Kristina Burrow | F | - |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | - |
Michael Rome | M | 39 |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | - |
Michael Rome | M | - |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | - |
Ido Morpurgo | M | 51 | 4 ans | |
Michael Dambach | M | 57 | 17 ans | |
Hagop Youssoufian | M | 67 | 7 ans | |
Karin Tollefson | M | 57 | 1 ans | |
Yisrael Gewirtz | M | 47 | 8 ans | |
Deina Walsh | F | 60 | 10 ans | |
William Berlin | M | - | - | |
Scott Biller | M | 68 |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | 4 ans |
Jonathan Pachter | M | 66 | 13 ans | |
David Mitchell | M | 67 | 1 ans | |
Don Hankey | M | 81 | 6 ans | |
Leon E. Chen | M | 49 |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | - |
Hadas Reuveni | M | 56 | 7 ans | |
Bertrand C. Liang | M | 61 | 4 ans | |
J. Goater | M | 48 |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | 1 ans |
Matt Patterson | M | 52 |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | 3 ans |
Michael Crowther | M | - | 1 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 84 | 84,00% |
Israël | 17 | 17,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Robert Gagnon
- Réseau Personnel